Variable | p53 in total HPSCC (n=97) | p53 in HPV(+) HPSCC (n=15) | p53 in HPV(-) HPSCC (n=82) | ||||||
---|---|---|---|---|---|---|---|---|---|
Low | High | p value | Low | High | p value | Low | High | p value | |
Age (years) | Â | Â | 0.9263 | Â | Â | 0.5804 | Â | Â | 0.6342 |
 ≤60 | 26 | 27 |  | 4 | 5 |  | 22 | 22 |  |
 >60 | 22 | 22 |  | 1 | 5 |  | 21 | 17 |  |
Smoking | Â | Â | 0.4495 | Â | Â | >0.9999 | Â | Â | 0.6439 |
 No | 14 | 11 |  | 1 | 1 |  | 13 | 10 |  |
 Yes | 34 | 38 |  | 4 | 9 |  | 30 | 29 |  |
Drinking | Â | Â | 0.9432 | Â | Â | 0.3333 | Â | Â | 0.6231 |
 No | 16 | 16 |  | 1 | 0 |  | 15 | 16 |  |
 Yes | 32 | 33 |  | 4 | 10 |  | 27 | 23 |  |
Tumor site | Â | Â | 0.3502 | Â | Â | >0.9999 | Â | Â | 0.3960 |
 Pyriform sinus | 40 | 44 |  | 4 | 8 |  | 36 | 36 |  |
 Not pyriform sinus | 8 | 5 |  | 1 | 2 |  | 7 | 3 |  |
cT stage | Â | Â | 0.2651 | Â | Â | 0.3287 | Â | Â | 0.5071 |
 T1-2 | 26 | 21 |  | 3 | 3 |  | 23 | 18 |  |
 T3-4 | 22 | 28 |  | 2 | 7 |  | 20 | 21 |  |
cN stage | Â | Â | 0.3756 | Â | Â | 0.5238 | Â | Â | 0.3083 |
 N0 | 9 | 6 |  | 0 | 2 |  | 9 | 4 |  |
 N1-3 | 39 | 43 |  | 5 | 8 |  | 34 | 35 |  |
Clinical stage | Â | Â | 0.9811 | Â | Â | >0.9999 | Â | Â | 0.6795 |
 I+II | 3 | 2 |  | 0 | 1 |  | 3 | 1 |  |
 III+IV | 45 | 47 |  | 5 | 9 |  | 40 | 38 |  |
pT stage | Â | Â | 0.0528 | Â | Â | 0.0769 | Â | Â | 0.2484 |
 T1-2 | 25 | 16 |  | 3 | 1 |  | 22 | 15 |  |
 T3-4 | 23 | 33 |  | 2 | 9 |  | 21 | 24 |  |
pN stage | Â | Â | 0.2133 | Â | Â | 0.5055 | Â | Â | 0.6044 |
 N0 | 3 | 8 |  | 0 | 3 |  | 3 | 5 |  |
 N1-3 | 45 | 41 |  | 5 | 7 |  | 40 | 34 |  |
Pathological stage | Â | Â | 0.3772 | Â | Â | >0.9999 | Â | Â | 0.2089 |
 I+II+III | 10 | 14 |  | 0 | 0 |  | 10 | 14 |  |
 IV | 38 | 35 |  | 5 | 10 |  | 33 | 25 |  |
Tumor differentiation | Â | Â | 0.5045 | Â | Â | >0.9999 | Â | Â | 0.6044 |
 Well+ well-moderately | 3 | 6 |  | 0 | 1 |  | 3 | 5 |  |
 Moderately+ Moderately-poorly | 45 | 43 |  | 5 | 9 |  | 40 | 34 |  |
Surgical margin status | Â | Â | 0.4765 | Â | Â | >0.9999 | Â | Â | 0.2700 |
 ≥0.5 cm | 26 | 23 |  | 3 | 6 |  | 23 | 17 |  |
 <0.5 cm | 22 | 26 |  | 2 | 4 |  | 20 | 24 |  |
Tumor size (cm) | Â | Â | 0.1135 | Â | Â | 0.5604 | Â | Â | 0.3098 |
 ≤3.5 | 33 | 26 |  | 2 | 2 |  | 31 | 24 |  |
 >3.5 | 15 | 23 |  | 3 | 8 |  | 12 | 15 |  |
Lymph nodal fusion | Â | Â | 0.5244 | Â | Â | >0.9999 | Â | Â | 0.6136 |
 No | 37 | 35 |  | 3 | 6 |  | 34 | 29 |  |
 Yes | 11 | 14 |  | 2 | 4 |  | 9 | 10 |  |
Metastatic lymph node size (cm) | Â | Â | 0.7256 | Â | Â | >0.9999 | Â | Â | 0.9405 |
 ≤3 | 32 | 31 |  | 3 | 5 |  | 29 | 26 |  |
 >3 | 16 | 18 |  | 2 | 5 |  | 14 | 13 |  |
Cervical nodal necrosis | Â | Â | 0.9263 | Â | Â | 0.1009 | Â | Â | 0.7097 |
 No | 26 | 27 |  | 0 | 5 |  | 26 | 22 |  |
 Yes | 22 | 22 |  | 5 | 5 |  | 17 | 17 |  |
Lymphovascular invasion | Â | Â | 0.9741 | Â | Â | 0.3333 | Â | Â | 0.8203 |
 No | 43 | 45 |  | 4 | 10 |  | 39 | 35 |  |
 Yes | 5 | 4 |  | 1 | 0 |  | 4 | 4 |  |
Extracapsular spread | Â | Â | 0.2555 | Â | Â | >0.9999 | Â | Â | 0.2963 |
 No | 39 | 35 |  | 3 | 6 |  | 36 | 29 |  |
 Yes | 9 | 14 |  | 2 | 4 |  | 7 | 10 |  |
Fixation of hemilarynx | Â | Â | 0.4790 | Â | Â | >0.9999 | Â | Â | 0.2368 |
 No | 25 | 22 |  | 4 | 8 |  | 21 | 14 |  |
 Yes | 23 | 27 |  | 1 | 2 |  | 22 | 25 |  |
Thyroid gland invasion | Â | Â | 0.1173 | Â | Â | >0.9999 | Â | Â | 0.2505 |
 No | 45 | 49 |  | 5 | 15 |  | 40 | 34 |  |
 Yes | 3 | 0 |  | 0 | 0 |  | 3 | 0 |  |
Laryngeal invasion | Â | Â | 0.6188 | Â | Â | 0.6084 | Â | Â | 0.7539 |
 No | 21 | 19 |  | 3 | 4 |  | 18 | 15 |  |
 Yes | 27 | 30 |  | 2 | 6 |  | 25 | 24 |  |